BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1155961)

  • 1. Immunity in tumours of the skin. Studies on cell-mediated immune reactions.
    Meneghini CL; Angelini G; Bonifazi E
    Arch Dermatol Forsch; 1975; 252(3):203-9. PubMed ID: 1155961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed cutaneous hypersensitivity reactions in patients with Kaposi's sarcoma.
    Taylor JF; Ziegler JL
    Br J Cancer; 1974 Oct; 30(4):312-8. PubMed ID: 4447775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immune response in the course of Kaposi's sarcoma].
    Scalise G; Mura MS; Piersimoni C; Manca S; Cherchi G; Andreoni G
    Boll Ist Sieroter Milan; 1980; 59(6):632-7. PubMed ID: 7236363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immunity in patients with basal and squamous cell skin cancer.
    Weimar VM; Ceilley RI; Goeken JA
    J Am Acad Dermatol; 1980 Feb; 2(2):143-7. PubMed ID: 6965945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed cutaneous hypersensitivity and peripheral lymphocyte counts in patients with advanced cancer.
    Lee YT; Sparks FC; Eilber FR; Morton DL
    Cancer; 1975 Mar; 35(3):748-55. PubMed ID: 1111942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal cell cancer and classic Kaposi's sarcoma in a locally immunocompromised patient.
    Ruocco V; Satriano RA
    Int J Dermatol; 1986 Nov; 25(9):594-6. PubMed ID: 3793361
    [No Abstract]   [Full Text] [Related]  

  • 7. Disseminated Kaposi's sarcoma without lymphocyte abnormalities.
    Ballard HS
    Arch Intern Med; 1985 Mar; 145(3):547. PubMed ID: 3872109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The immune status of patients with lymphoproliferative diseases of the skin and Kaposi's sarcoma].
    Faradzhev ZG; Derevnina NA; Ivshina AV
    Vestn Dermatol Venerol; 1990; (1):16-20. PubMed ID: 2327165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immunity in patients with carcinoma: correlation between clinical stage and immunocompetence.
    Kopersztych S; Rezkallah MT; Miki SS; Naspitz CK; Mendes NF
    Cancer; 1976 Sep; 38(3):1149-54. PubMed ID: 1085193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte transformation in Kaposi's sarcoma.
    Taylor JF
    Lancet; 1973 Apr; 1(7808):883-4. PubMed ID: 4123428
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dynamics of immunologic indices in patients with Kaposi's sarcoma during treatment with the preparation leakadine].
    Gorshkova NI; Samsonov VA; Mazina NM; Parastaev SA
    Vestn Dermatol Venerol; 1989; (9):6-10. PubMed ID: 2609769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Demonstration of complex dysregulation of anti-cytomegalovirus T-cellular immunity in Kaposi's sarcoma following renal transplantation].
    Charpentier B; Lang P; Hiesse C; Fixy P; Lantz O; Bellamy J; Benoit G; Fries D
    Ann Med Interne (Paris); 1987; 138(5):366-8. PubMed ID: 2823665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Skin reactions of delayed hypersensitivity in melanoblastoma].
    Ryzhkov VI; Potapenkova LS; Korosteleva TA; Khachaturian LM
    Vopr Onkol; 1979; 25(4):3-6. PubMed ID: 433214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dinitrochlorobenzene skin sensitization and peripheral lymphocyte count: predictors of survival in head and neck cancer.
    Maisel RH; Ogura JH
    Ann Otol Rhinol Laryngol; 1976; 85(4 Pt 1):517-22. PubMed ID: 949158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte transformation during dinitrochlorobenzene contact sensitization. An in vitro and in vivo evaluation of the primary immune response in man.
    Miller AE; Levis WR
    J Clin Invest; 1973 Aug; 52(8):1925-30. PubMed ID: 4719669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dermal cellular infiltrate and cell-mediated immunity in skin carcinomas.
    Avgerinou G; Nicolis G; Vareltzidis A; Stratigos J
    Dermatologica; 1985; 171(4):238-42. PubMed ID: 4076497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed hypersensitivity in patients with bronchial carcinoma.
    Pauwels R; van der Straeten M
    Scand J Respir Dis; 1975 Sep; 56(3):160-4. PubMed ID: 1162307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Disordered cell-receptor metabolism (R-proteins) and the immunity indices in patients with lymphoproliferative diseases of the skin and Kaposi's sarcoma].
    Faradzhev ZG; Samsonov VA; Bukhova VP
    Vestn Dermatol Venerol; 1990; (10):17-20. PubMed ID: 2177582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [AIDS-associated Kaposi's sarcoma: 22 cases].
    Dhrif AS; Kilani B; Ammari L; Kanoun F; Tiouri H; Ben Chaaben T
    Tunis Med; 2007 Jun; 85(6):494-9. PubMed ID: 17644904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
    Moszkowska G; Jassem J; Kondrat W; Kopacz A; GoszczyƄska E
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.